Fulcrum Therapeutics, Inc. - FULC
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 04, 2026 | — | S | D | 15,000.0 | 10.8726 | 163,089.0 | 469,864.0 | View | |
| Feb 04, 2026 | Chief Legal Officer | A | A | 170,000.0 | 0.0 | 0.0 | 170,000.0 | View | |
| Feb 04, 2026 | Chief Financial Officer | A | A | 170,000.0 | 0.0 | 0.0 | 170,000.0 | View | |
| Feb 04, 2026 | — | S | D | 15,000.0 | 10.7238 | 160,857.0 | 454,864.0 | View | |
| Feb 04, 2026 | Principal Accounting Officer | A | A | 57,000.0 | 0.0 | 0.0 | 57,000.0 | View | |
| Feb 04, 2026 | See Remarks | A | A | 650,000.0 | 0.0 | 0.0 | 650,000.0 | View | |
| Jan 06, 2026 | — | S | D | 15,000.0 | 11.8726 | 178,089.0 | 469,864.0 | View | |
| Dec 17, 2025 | Chief Legal Officer | S | D | 3,452.0 | 12.92 | 44,599.84 | 10,252.0 | View | |
| Dec 10, 2025 | — | S | D | 91,722.0 | 14.98 | 1,373,995.56 | 6,053,960.0 | View | |
| Dec 10, 2025 | — | S | D | 2,706,397.0 | 14.28 | 38,647,349.16 | 6,145,682.0 | View | |
| Dec 10, 2025 | — | S | D | 1,377,020.0 | 13.33 | 18,355,676.6 | 8,852,079.0 | View | |
| Nov 21, 2025 | — | S | D | 15,000.0 | 11.033 | 165,495.0 | 484,864.0 | View |